- Home
- PTGX vs BLSH Comparison
PTGX vs BLSH Comparison
Compare PTGX & BLSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PTGX | BLSH |
|---|---|---|
| Founded | 2006 | 2020 |
| Country | US | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 5.8B |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | PTGX | BLSH |
|---|---|---|
| Price | $82.25 | $31.25 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 12 |
| Target Price | ★ $99.20 | $52.09 |
| AVG Volume (30 Days) | 600.9K | ★ 2.8M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 404.32 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $65.46 |
| Revenue Next Year | $501.99 | $16.10 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $33.70 | $24.69 |
| 52 Week High | $96.54 | $74.98 |
Technical Indicators
Market Signals| Indicator | PTGX | BLSH |
|---|---|---|
| Relative Strength Index (RSI) | 46.98 | 41.75 |
| Support Level | $80.40 | $30.30 |
| Resistance Level | $83.40 | $32.69 |
| Average True Range (ATR) | 3.21 | 2.12 |
| MACD | 0.04 | 0.56 |
| Stochastic Oscillator | 45.85 | 75.43 |
Price Performance
Historical ComparisonAbout PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About BLSH Bullish Ordinary Shares
Bullish is an institutionally focused global digital asset platform focused on providing market infrastructure and information services. Its objective is to provide mission critical products and services that are designed to help institutions grow their businesses, empower individual investors, and drive the adoption of stablecoins, digital assets, and blockchain technology. It expanded its product offering to provide trusted insights, authoritative news, data, indices and transparent analysis to the digital assets industry while facilitating partnerships, investment opportunities, and community engagement through its flagship Consensus conference.